Description: 1990 Valuation Actuary Symposium Proceedings that is a panel discussion on AIDS and the valuation actuary. In addition, the panel will discuss the cost of treating HIV infection at Empire Blue Cross and Blue Shield.

Description: This session 110IF of the Las Vegas Spring Meeting updates the changes in the health insurance industry due to recent mergers, acquisitions, and demutualizations. What has the impact of this consolidation been on health products? What is the outlook for continued future consolidations in the health insurance industry? From Record of Society of Actuaries, Volume 26, No 1.

Description: The panel will present a discussion by several experts on reform activity at the state level, including a review of some initial results. From the Record of the Society of Actuaries, Vol. 21, No. 4a.

Description: Panel discussion about the impact of wellness programs on medical plan experience, health status pricing trends, legal implications and future developments. From the 1987 Record of Society of Actuaries, Vol. 13, No. 1.

Description: Summary of research from the Initiative 18/11 - Pharmacy team about the drug development process for traditional pharmaceuticals: Who does the research and discovery? What does the research and discovery process entail? How are targets identified and validated for research and discovery? What are clinical trials and how are they conducted? How is the drug development process regulated? How is the drug development process funded?

Description: This session discussed A successful HMO An emerging PPO A dynamic employer coalition An industry-sponsored wellness at the worksite program. Record of the Society of Actuaries Vol. 10, No. 2 at Salt Lake City

Description: This session discussion is about under 25 life group medical reform, model bills, state variations, congressional proposal, community rate implications, effect of RBRVS on provider fees and plan cost. From Record of Society of Actuaries Vol. 17, No. 4A.

Description: Telehealth enables the delivery of health care services to patients that are not in the same location as providers. Over the past decade, telehealth has been used increasingly to complement face-to-face patient encounters, and is particularly important to addressing health care needs in rural areas. Recent regulatory catalysts, particularly in the Medicare Advantage program, have served to elevate the visibility and importance of telehealth in the overall health care delivery system. Starting in 2020, Medicare Advantage plans can offer any clinically appropriate physician services through telehealth as part of the standard Medicare benefit. Network adequacy standards can also be met via telehealth providers under certain programs. This presentation will cover the basics of what constitutes telehealth, and provide tangible demonstrations of telehealth technology (simulating variations mediums through which services are delivered). We will cover the what, the why, and the where (anywhere) of telehealth in 2020.

Description: At the beginning of 1999, a new model regulation is expected to be approved by the National Association of Insurance Commissioners and will regulate risk-based capital for managed care organizations. Panelists describe the regulation and offer insights into the why, wherefore, and whereto. They consider the potential impact of the new regulation on the current life insurance company risk-based capital regulation that governs traditional health carriers.

Description: This discussion at the SOA 1967 Annual Meeting covers three topics. First is the Carter Commission Report that recommends radical changes to the Canadian tax system. Second is a report on U.S. federal government activities in the health market. Third is an update on variable annuities.